Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L Corless

Showing results (11-20 of 208) with videos related to

Pageof 21
Sort By:
Cancer Investigation|June 11, 2005
State-of-the art therapy for gastrointestinal stromal tumorsCharles D Blanke, Christopher L Corless
Lancet (London, England)|April 30, 2013
Gastrointestinal stromal tumourHeikki Joensuu, Peter Hohenberger, Christopher L Corless
Cureus|September 22, 2022
Biclonal Desmoid-Type Fibromatosis With Two Beta-Catenin Mutations: Evidence for the Recruitment of Normal MyofibroblastsKeith M Skubitz, Paari Murugan, Christopher L Corless
Nature Reviews. Cancer|November 18, 2011
Gastrointestinal stromal tumours: origin and molecular oncologyChristopher L Corless, Christine M Barnett, Michael C Heinrich
JAMA Oncology|March 24, 2017
Defining the Impact of Adjuvant Therapy in Molecularly Defined Subsets of Gastrointestinal Stromal Tumor : From Lumping to SplittingMichael C Heinrich, Christopher L Corless, George D Demetri
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2004
Biology of gastrointestinal stromal tumorsChristopher L Corless, Jonathan A Fletcher, Michael C Heinrich
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2009
Resistance to Tyrosine Kinase Inhibitors in Gastrointestinal Stromal TumorsAnn W Gramza, Christopher L Corless, Michael C Heinrich
Hematology/Oncology Clinics of North America|October 8, 2013
Gastrointestinal stromal tumors: molecular markers and genetic subtypesChristine M Barnett, Christopher L Corless, Michael C Heinrich
Lancet (London, England)|May 22, 2007
Gastrointestinal stromal tumourBrian P Rubin, Michael C Heinrich, Christopher L Corless
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2021
Inhibition of KIT Tyrosine Kinase Activity: Two Decades After the First ApprovalLillian R Klug, Christopher L Corless, Michael C Heinrich
Pageof 21

Showing results (11-20 of 208) with videos related to

Sort By:
Pageof 21
Cancer Investigation|June 11, 2005
State-of-the art therapy for gastrointestinal stromal tumorsCharles D Blanke, Christopher L Corless
Lancet (London, England)|April 30, 2013
Gastrointestinal stromal tumourHeikki Joensuu, Peter Hohenberger, Christopher L Corless
Cureus|September 22, 2022
Biclonal Desmoid-Type Fibromatosis With Two Beta-Catenin Mutations: Evidence for the Recruitment of Normal MyofibroblastsKeith M Skubitz, Paari Murugan, Christopher L Corless
Nature Reviews. Cancer|November 18, 2011
Gastrointestinal stromal tumours: origin and molecular oncologyChristopher L Corless, Christine M Barnett, Michael C Heinrich
JAMA Oncology|March 24, 2017
Defining the Impact of Adjuvant Therapy in Molecularly Defined Subsets of Gastrointestinal Stromal Tumor : From Lumping to SplittingMichael C Heinrich, Christopher L Corless, George D Demetri
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2004
Biology of gastrointestinal stromal tumorsChristopher L Corless, Jonathan A Fletcher, Michael C Heinrich
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2009
Resistance to Tyrosine Kinase Inhibitors in Gastrointestinal Stromal TumorsAnn W Gramza, Christopher L Corless, Michael C Heinrich
Hematology/Oncology Clinics of North America|October 8, 2013
Gastrointestinal stromal tumors: molecular markers and genetic subtypesChristine M Barnett, Christopher L Corless, Michael C Heinrich
Lancet (London, England)|May 22, 2007
Gastrointestinal stromal tumourBrian P Rubin, Michael C Heinrich, Christopher L Corless
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2021
Inhibition of KIT Tyrosine Kinase Activity: Two Decades After the First ApprovalLillian R Klug, Christopher L Corless, Michael C Heinrich
Pageof 21